 6. Adequate baseline hematological and organ function, assessed by laboratory values within 42 days 6 weeks prior to study entry and prior to repeat treatment cycles with INXN-1001 as follows: hemoglobin 10 gL, granulocytes 2500mm3, lymphocytes 1000 mm3, platelets 100,000 mm3, serum creatinine 1.5 x ULN, AST, ALT, alkaline phosphatase 2.5 x ULN, LDH 2 x ULN, serum bilirubin 1.5 x ULN, absolute neutrophils 500 mm3; 